COMMUNIQUÉS West-GlobeNewswire

Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder
20/08/2019
Press Release, Helsinki, 20 August 2019 at 10.00 am (EET) Nexstim reports good initial results on the use of Smartfocus ® technology in treatment of major depressive disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim [...]
Coloplast: Announcement no. 8/2019 - Meet the Management Event 2019
20/08/2019
Announcement No. 8 /2019 20 August, 2019 Coloplast’s Meet the Management Event in London Coloplast is hosting a Meet the Management Event in London today at 10:30 local time. The purpose of the event is to provide [...]
Araris Biotech AG closes seed financing round of CHF 2.5 million
20/08/2019
Redalpine, Schroder Adveq and VI Partners participated in round Proceeds to support development of own antibody-drug-conjugates (ADCs) ZURICH, Switzerland, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Araris Biotech AG announced [...]
Nomination committee in Oasmia for the 2019 AGM
20/08/2019
In accordance with the decision at the Annual General Meeting of Oasmia Pharmaceutical AB on September 25, 2018, the two largest shareholders in terms of voting rights who have chosen to participate in the Nomination [...]
Immunicum AB (publ) Interim Report January – June 2019
20/08/2019
Press Release 20 August 2019 Immunicum AB (publ) Interim Report January – June 2019 Positive results from GIST study and MERECA data approaching SIGNIFICANT EVENTS DURING APRIL - JUNE Net sales for the period amounted [...]
NeuroSearch – Updated financial calendar for 2019
20/08/2019
Announcement 20 August 2019 NeuroSearch A/S (NEUR) hereby announces an updated company’s financial calendar for 2019. 21 August 2019 Interim report for H1 2019 (will be released after 5 p.m.) Allan Andersen CEO Contact [...]
Oxurion NV Reports Topline Month 3 Results of Phase 2a Study Evaluating THR-317 (anti-PLGF), in Combination with Ranibizumab, for DME
20/08/2019
Combination therapy did not show increase in BCVA in the overall population at Month 3. Certain improvement in mean BCVA at Month 3 observed with the combination therapy in 2 pre-specified subgroups: poor (or non) [...]
Basilea reports significantly increased cash-generating revenue, flat operating expenses and reduced net loss for half-year 2019
20/08/2019
Revenue from Cresemba ® and Zevtera ® increased by 91% to CHF 53 million Operating result improved by 35% Expansion of derazantinib clinical program into urothelial cancer with immunotherapy combination Positive phase 3 [...]
Eve & Co Announces Financial Results for the Three and Six Month Periods Ended June 30, 2019
20/08/2019
TORONTO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its interim financial results for the three and six month periods [...]
Waterloo Wellington signs onto national suicide prevention project, Roots of Hope
20/08/2019
Media Advisory From Mental Health Commission of Canada and Waterloo Region Suicide Prevention Council CAMBRIDGE, Ontario, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Tomorrow, the Mental Health Commission of Canada (MHCC) will [...]
Waterloo Wellington adhère au projet national de prévention du suicide Enraciner l’espoir
20/08/2019
Avis aux médias De Commission de la santé mentale du Canada et Waterloo Region Suicide Prevention Council CAMBRIDGE, Ontario, 19 août 2019 (GLOBE NEWSWIRE) -- Demain, la Commission de la santé mentale du Canada (CSMC) [...]
Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
19/08/2019
CAMBRIDGE, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced it had received a Complete Response Letter (CRL) [...]
Predictive Oncology Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update
19/08/2019
Management to Host Conference Call to Review Financial Results and Provide Corporate Update at 5:30PM Today MINNEAPOLIS, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology [...]
R1 RCM to Present at the Baird 2019 Global Healthcare Conference
19/08/2019
CHICAGO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants
19/08/2019
CANTON, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company”) announced today the completion of its previously announced exchange offer (the “Offer”) and consent [...]
Atrion Corporation Increases Quarterly Cash Dividend by 15%
19/08/2019
ALLEN, Texas, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.35 per share to $1.55 per share. Specifically, the Board of Directors [...]
The Ensign Group Announces Appointment of Chief Financial Officer of The Pennant Group
19/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
Merus Announces Financial Results for the Second Quarter 2019 and Provides Business Update
19/08/2019
UTRECHT, The Netherlands, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)
19/08/2019
First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP XENLETA Expected to be Available mid-September [...]

Pages